Closed consultation

Clostridioides difficile infection: guidance on management and treatment

• From: UK Health Security Agency
• Published: 13 July 2022

This consultation was withdrawn on 19 May 2023

For current antimicrobial prescribing options, refer to the National Institute for Health and Care Excellence (NICE) guidance for Clostridioides difficile infection: antimicrobial prescribing, known as NG199.

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

Summary

This consultation asks for feedback on new guidance for the management and treatment of Clostridioides difficile infection.

This consultation ran from
9am on 13 July 2022 to 5pm on 14 October 2022

Consultation description

The UK Health Security Agency (UKHSA) has opened a consultation on the new edition of its guidance for the management and treatment of Clostridioides difficile infection.

This guidance includes recommendations and algorithms for the antimicrobial treatment of C. difficile infection, as well as advice relating to diagnostic criteria, severity assessment, infection prevention and control (IPC) measures, and non-antimicrobial therapeutics such as faecal microbiota transplantation (FMT). 

We welcome comments from healthcare professionals on the draft guidance. The consultation will close at 5pm on Friday 14 October.

Use this form to provide feedback.

Documents

C. difficile infection: Updated guidance on management and treatment - closed consultation draft

Ref: UKHSA publication gateway number GOV-12513

PDF, 2.92 MB, 33 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Published 13 July 2022